[HTML][HTML] Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment
J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
Single-and multifraction stereotactic radiosurgery dose/volume tolerances of the brain
Purpose As part of the American Association of Physicists in Medicine Working Group on
Stereotactic Body Radiotherapy investigating normal tissue complication probability (NTCP) …
Stereotactic Body Radiotherapy investigating normal tissue complication probability (NTCP) …
Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial
LGW Kerkmeijer, VH Groen, FJ Pos… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE This study investigates whether focal boosting of the macroscopic visible tumor
with external beam radiotherapy increases biochemical disease-free survival (bDFS) in …
with external beam radiotherapy increases biochemical disease-free survival (bDFS) in …
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
FX Lescure, H Honda, RA Fowler, JS Lazar… - The Lancet …, 2021 - thelancet.com
Background Elevated proinflammatory cytokines are associated with greater COVID-19
severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor …
severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor …
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …
A Kneebone, C Fraser-Browne, GM Duchesne… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …
progression for patients with high-risk disease after radical prostatectomy. Early salvage …
Long-term results of NRG oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell …
JD Bradley, C Hu, RR Komaki, GA Masters… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE RTOG 0617 compared standard-dose (SD; 60 Gy) versus high-dose (HD; 74 Gy)
radiation with concurrent chemotherapy and determined the efficacy of cetuximab for stage …
radiation with concurrent chemotherapy and determined the efficacy of cetuximab for stage …
[HTML][HTML] Role of gold nanoparticles in advanced biomedical applications
Gold nanoparticles (GNPs) have generated keen interest among researchers in recent years
due to their excellent physicochemical properties. In general, GNPs are biocompatible …
due to their excellent physicochemical properties. In general, GNPs are biocompatible …
[HTML][HTML] Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority …
D Dearnaley, I Syndikus, H Mossop, V Khoo… - The Lancet …, 2016 - thelancet.com
Background Prostate cancer might have high radiation-fraction sensitivity that would give a
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
therapeutic advantage to hypofractionated treatment. We present a pre-planned analysis of …
Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee
Purpose To develop a new adverse event (AE) classification for the interventional radiology
(IR) procedures and evaluate its clinical, research, and educational value compared with the …
(IR) procedures and evaluate its clinical, research, and educational value compared with the …
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer
H Wildiers, P Heeren, M Puts, E Topinkova… - Journal of clinical …, 2014 - ascopubs.org
Purpose To update the International Society of Geriatric Oncology (SIOG) 2005
recommendations on geriatric assessment (GA) in older patients with cancer. Methods SIOG …
recommendations on geriatric assessment (GA) in older patients with cancer. Methods SIOG …